Trades on 3 secondary markets

ArsenalBio

ArsenalBio is a privately held, clinical-stage biotechnology company in South San Francisco developing programmable, integrated cell therapies for solid tumors. Its platform engineers autonomous CAR-T cells using large-scale genome engineering and computational biology to create multi-functional the

minimal 7.7 / 100 0 APIs View provider profile →

Company Healthcare Biotechnology Cell Therapy Immuno-Oncology Drug Discovery

ArsenalBio is an API provider whose private shares are listed on 3 secondary markets: Hiive, EquityZen, Nasdaq Private Market.

Where It Trades

H Hiive View listing → EZ EquityZen View listing → N Nasdaq Private Market View listing →

Listing data is compiled from the public marketplace pages of Forge Global, Hiive, EquityZen, Nasdaq Private Market, and Augment. A listing indicates that a venue has published a page for this company — it is not an offer, a quote, or investment advice, and APIs.io has no affiliation with any venue.